These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1831745)
41. [Relation of T-lymphocyte subsets and symptom complex groups of patients with chronic aplastic anemia]. Ma R Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Mar; 12(3):142-4, 131. PubMed ID: 1504530 [TBL] [Abstract][Full Text] [Related]
43. Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia. Zheng M; Liu C; Fu R; Wang H; Wu Y; Li L; Liu H; Ding S; Shao Z Int J Clin Exp Pathol; 2015; 8(4):3659-69. PubMed ID: 26097547 [TBL] [Abstract][Full Text] [Related]
44. Circulating activated suppressor T lymphocytes in aplastic anemia. Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406 [TBL] [Abstract][Full Text] [Related]
45. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines. van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925 [TBL] [Abstract][Full Text] [Related]
46. [Analysis of Correlation of Immune T Cell Subsets, TNF-α, IFN-γ and sFas levels with Severity and Prognosis in Aplastic Anemia Patients]. Su AY; Yang XZ; Zhang MH; DI ZX; Li Q Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1459-1464. PubMed ID: 30295268 [TBL] [Abstract][Full Text] [Related]
47. [A preliminary study on the changes of T-cell subsets in patients with aplastic anemia treated with qigong]. Yao BS Zhong Xi Yi Jie He Za Zhi; 1989 Jun; 9(6):341-2, 324. PubMed ID: 2528428 [TBL] [Abstract][Full Text] [Related]
48. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832 [TBL] [Abstract][Full Text] [Related]
49. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122 [TBL] [Abstract][Full Text] [Related]
50. [Association between serum interleukin-17 level and abnormal cellular immunological status in patients with severe aplastic anemia]. Qi W; Fu R; Wang H; Liu C; Liu H; Shao Y; Ren Y; Tao J; Shao Z Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1539-42. PubMed ID: 25146740 [TBL] [Abstract][Full Text] [Related]
52. Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy. Mentzel U; Vogt H; Rossol R; Geissler RG; Maurer A; Ganser A; Trommer WE; Hoelzer D Ann Hematol; 1993 Mar; 66(3):127-9. PubMed ID: 8471657 [TBL] [Abstract][Full Text] [Related]
53. Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. Hosokawa K; Muranski P; Feng X; Townsley DM; Liu B; Knickelbein J; Keyvanfar K; Dumitriu B; Ito S; Kajigaya S; Taylor JG; Kaplan MJ; Nussenblatt RB; Barrett AJ; O'Shea J; Young NS J Immunol; 2016 Feb; 196(4):1568-78. PubMed ID: 26764034 [TBL] [Abstract][Full Text] [Related]
54. Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms. Tancini G; Barni S; Rescaldani R; Fiorelli G; Vivani S; Lissoni P Oncology; 1990; 47(5):381-4. PubMed ID: 2145536 [TBL] [Abstract][Full Text] [Related]
55. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance]. Cui JX; Pei MF; Zhang GS; Xu M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129 [TBL] [Abstract][Full Text] [Related]
56. Lymphocyte subsets in patients with aplastic anemia. Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Marín-López A; González-Llaven J; Cano-Castellanos R Am J Hematol; 1984 Apr; 16(3):267-75. PubMed ID: 6231856 [TBL] [Abstract][Full Text] [Related]
57. Reduced helper (OKT4+): suppressor (OKT8+) T ratios in aplastic anaemia: relation to immunosuppressive therapy. Kuriyama K; Tomonaga M; Jinnai I; Matsuo T; Yoshida Y; Amenomori T; Yamada Y; Ichimaru M Br J Haematol; 1984 Jun; 57(2):329-36. PubMed ID: 6234016 [TBL] [Abstract][Full Text] [Related]
58. Lymphocyte subsets and mitogen induced proliferation in adjuvant arthritis. Part III. Numbers and functions of T lymphocytes in spleen. Tsai CL; Liu TK Tohoku J Exp Med; 1992 Mar; 166(3):289-96. PubMed ID: 1533962 [TBL] [Abstract][Full Text] [Related]
59. Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia. Köller U; Hinterberger W; Gschwandtler L; Grümayer R; Majdic O; Knapp W Blut; 1989 Jan; 58(1):21-6. PubMed ID: 2521803 [TBL] [Abstract][Full Text] [Related]
60. Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria. Vellenga E; Ensing GJ; Halie MR; Kallenberg CG; Mulder NH; Nieweg HO; The TH Blut; 1983 Aug; 47(2):77-83. PubMed ID: 6223677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]